By the time an artificial intelligence system is presented as ready for deployment, many consequential features may already be difficult to change. Its purpose has been framed. A decision has been made to build, buy or enter into a partnership. Data sources, success measures, vendor terms and levels of human involvement may already be embedded. Capital has been committed, and executives may have attached their credibility to the initiative.
If this is the board’s first meaningful encounter with a material AI use, oversight has arrived late.
AI governance is often associated with the point at which a system goes live. Yet deployment is only one decision in a longer chain. Earlier choices shape what the system will optimise, whose interests it may affect, what dependencies the organisation accepts and whether it can later change course. Decisions after deployment determine whether continued confidence remains justified.
This is why AI oversight must extend across the lifecycle. National Institute of Standards and Technology’s (NIST) AI Risk Management Framework applies trustworthiness considerations to the design, development, use and evaluation of AI systems. The OECD calls for systematic risk management throughout the AI lifecycle, including monitoring and, where appropriate, retirement from production. The EU AI Act similarly requires providers of high-risk systems to monitor performance throughout their lifetime. The common principle is clear: governance cannot be reduced to approval at launch.
For boards, lifecycle oversight does not mean directing technical development or approving every AI use case. Management remains responsible for exploration, procurement, development, validation, deployment and monitoring. The board’s role is to ensure that material AI decisions receive appropriate scrutiny while the organisation still has meaningful choices.
Materiality is therefore the boundary. A productivity assistant used for routine drafting does not require the same attention as AI that determines access to credit, influences clinical care, directs employees, moves funds or acts autonomously across business systems. Board visibility should increase where AI could materially affect strategy, capital allocation, customers’ rights, critical operations, regulatory standing or the organisation’s licence to operate.
The route to acquiring AI also changes the governance questions. When an organisation builds, the board should be satisfied that management has the expertise, data rights and resources to sustain accountability. When it buys, attention shifts towards vendor evidence, audit rights, material system changes, data use and exit arrangements. Where it partners, decision rights, intellectual property, liability, escalation and termination become especially important. Procurement may transfer work, but it does not transfer responsibility for the context in which AI is used.
Board oversight should concentrate on consequential moments. At conception, is the proposed purpose aligned with strategy and organisational values? Before substantial commitment, has management examined the implications of building, buying or partnering? Before deployment, is there credible evidence that the system is suitable for its intended use? During operation, is the board receiving timely information that reveals changes in value, performance or exposure? When assumptions no longer hold, can the organisation constrain, redesign, replace or retire the system?
These questions matter because AI systems and their environments do not remain fixed. Data changes. Vendors update models. Employees develop new patterns of reliance. A tool introduced for one purpose may quietly be extended to another. Risks that appeared limited at launch can become material as scale, authority or stakeholder impact increases.
The board should expect management to identify the assumptions on which a material AI decision depends, the evidence supporting continued use and the conditions requiring reconsideration. Initial approval must not become permanent authorisation simply because investment has been made.
The strongest lifecycle governance preserves organisational choice. It allows an enterprise to pursue innovation without becoming trapped by sunk cost, vendor dependence or misplaced confidence. A defensible organisation governs AI early enough to shape the decision, continuously enough to recognise when its assumptions have changed and deliberately enough to withdraw when continued use can no longer be justified.
The board need not manage the lifecycle. It must ensure that the organisation can govern what happens throughout it.
Amaka Ibeji is a Boardroom Certified Qualified Technology Expert and a Digital Trust Visionary. She is the founder of PALS Hub, a digital trust and assurance company. Amaka coaches and consults with individuals and companies navigating careers or practices in privacy and AI governance. Connect with her on LinkedIn: amakai or email [email protected]
Related News
